CAN
AVNS icon

Claraphi Advisory Network’s Avanos Medical AVNS Stock Holding History

Claraphi Advisory Network’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5
Closed – – 354
2020
Q1 		$0 Buy
+5
New +$149 ﹤0.01% 1164

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Claraphi Advisory Network's AVNS Position: Q2 2020 in Review

Claraphi Advisory Network sold out of Avanos Medical (AVNS) in Q2 2020, closing a stake of 5 shares.

Claraphi Advisory Network first reported a position in AVNS in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 277 funds tracked by Wall St. Rank hold AVNS as of Q2 2020.

  • Claraphi Advisory Network reported no remaining Avanos Medical position as of Q2 2020 after selling out during the quarter.
  • Claraphi Advisory Network sold 5 Avanos Medical shares in Q2 2020.
  • Claraphi Advisory Network first reported a position in Avanos Medical in Q1 2020 and held it in 1 quarter.
  • Claraphi Advisory Network's Avanos Medical position peaked at $0 in Q1 2020.
  • 277 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2020.

Based on Claraphi Advisory Network's 13F filing for Q2 2020, filed 14 Aug 2020.